Matches in Wikidata for { <http://www.wikidata.org/entity/Q93217952> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q93217952 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93217952 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93217952 description "scientific article published on 24 April 2020" @default.
- Q93217952 description "wetenschappelijk artikel" @default.
- Q93217952 description "наукова стаття, опублікована 24 квітня 2020" @default.
- Q93217952 description "գիտական հոդված հրատարակված 2020 թվականի ապրիլի 24-ին" @default.
- Q93217952 name "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 name "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 type Item @default.
- Q93217952 label "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 label "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 prefLabel "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 prefLabel "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 P1433 Q93217952-D7E00F7C-CBF0-4780-AFA0-9CEA355349E9 @default.
- Q93217952 P1476 Q93217952-207FA0DA-25BE-4C7C-A4A7-C7D43A1485A2 @default.
- Q93217952 P2093 Q93217952-08CD91BE-887B-400D-B3D0-A386AA5FDA44 @default.
- Q93217952 P2093 Q93217952-27ABFA73-9CC5-445C-85C9-60C2C04FB9E0 @default.
- Q93217952 P2093 Q93217952-2E867C60-9EE9-4075-9153-B73BAF7DD486 @default.
- Q93217952 P2093 Q93217952-60C81CD7-B1B2-4AD0-B5CF-8AC25626BC86 @default.
- Q93217952 P2093 Q93217952-654A49C2-C3FC-43DE-8F1F-ED0CF4C56D9D @default.
- Q93217952 P2093 Q93217952-AD9EDBEC-1047-4A5D-8345-233C2D140FDF @default.
- Q93217952 P2093 Q93217952-DB17FE14-BAB6-4E7D-ACB8-B764C9C05F67 @default.
- Q93217952 P2093 Q93217952-E799944E-1FD8-43EE-8BBE-D17F46B65CE0 @default.
- Q93217952 P31 Q93217952-17871565-EE5A-4AFB-88B1-DEA2C87D0FFB @default.
- Q93217952 P356 Q93217952-3E073CC9-CA4E-4AB0-A53A-AFCFAFE84F71 @default.
- Q93217952 P577 Q93217952-B98EF9C2-79F1-48A4-8400-058566DCE392 @default.
- Q93217952 P698 Q93217952-1E3B022A-E0FA-4078-82EF-245AFA9DAE52 @default.
- Q93217952 P356 S00432-020-03213-X @default.
- Q93217952 P698 32333143 @default.
- Q93217952 P1433 Q2081599 @default.
- Q93217952 P1476 "Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells" @default.
- Q93217952 P2093 "Guan-Ling Chou" @default.
- Q93217952 P2093 "Joel-Sean Hsu" @default.
- Q93217952 P2093 "Meng-Hsun Hsieh" @default.
- Q93217952 P2093 "Sevil Zencir" @default.
- Q93217952 P2093 "Shu-Chun Teng" @default.
- Q93217952 P2093 "Tsai-Kun Li" @default.
- Q93217952 P2093 "Yavuz Ergun" @default.
- Q93217952 P2093 "Zeki Topcu" @default.
- Q93217952 P31 Q13442814 @default.
- Q93217952 P356 "10.1007/S00432-020-03213-X" @default.
- Q93217952 P577 "2020-04-24T00:00:00Z" @default.
- Q93217952 P698 "32333143" @default.